To verify the effect of the STING inhibitor on diabetes-related macrophage senescence, we established a diabetic mouse model through the intraperitoneal injection of streptozotocin (STZ) and treated the mice with H-151. The gene discussed is STING1; the disease is diabetes mellitus.